We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NUVL market cap is 5.93B. The company's latest EPS is USD -1.7764 and P/E is -47.85.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.78M | -46.44M | -52.59M | -65.15M | -76.33M |
| Net Income | -33.65M | -38.29M | -44.48M | -57.17M | -84.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.36M | -16.91M | -45.82M | -86.11M | -149.49M |
| Net Income | -11.81M | -14.56M | -46.34M | -81.85M | -126.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 425.08M | 732.38M | 708.47M | 675.23M | 1.19B |
| Total Liabilities | 29.1M | 31.82M | 33.43M | 38.19M | 67.73M |
| Total Equity | 395.98M | 700.56M | 675.04M | 637.04M | 1.12B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.32M | 10.65M | 293.82M | 482.46M | 732.38M |
| Total Liabilities | 6.52M | 6.62M | 8.79M | 19.48M | 31.82M |
| Total Equity | -17.26M | -31.32M | 285.04M | 462.98M | 700.56M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -69.53M | -99.74M | -36.09M | -77.25M | -123.06M |
| Investing | -87.27M | -143.53M | -206.77M | -190.56M | -403.47M |
| Financing | 3.42M | 336.85M | 5.99M | 10.12M | 560.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.64M | -14.95M | -40M | -64.97M | -99.74M |
| Investing | N/A | N/A | -220.03M | -10.67M | -143.53M |
| Financing | N/A | 22.27M | 318.22M | 248.92M | 336.85M |
| Market Cap | 5.93B |
| Price to Earnings Ratio | -47.85 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 18.01 |
| Price to Book Ratio | 8.62 |
| Dividend Yield | - |
| Shares Outstanding | 71.05M |
| Average Volume (1 week) | 615.9k |
| Average Volume (1 Month) | 369.14k |
| 52 Week Change | 4.77% |
| 52 Week High | 113.51 |
| 52 Week Low | 61.795 |
| Spread (Intraday) | 8.32 (9.58%) |
| Company Name | Nuvalent Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.nuvalent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
